Small Cell Lung Cancer
- Compensation to be determined
- 13 visits (enrollment open)
18+ Years
Male or Female
Smoker & Non-Smoker
ShareDescription
A Randomized, Atezolizumab-Controlled Study to Evaluate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in US Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC).
ES- SCLC (extensive stage small cell lung cancer) is a kind of lung cancer. The cancer cell of ES-SCLC can produce chemicals that cause endocrine abnormality. Most patients present with tumor metastases (cancer cells spread over the body) as the first symptom. Currently, systematic chemotherapy or immunotherapy combined with platinum-based treatment are the primary treatment for ES-SCLC.
The purpose of this study is to compare the effects of the study drug plus chemotherapy with atezolizumab plus chemotherapy on you and your disease.
